CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 2.66: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.60%Above 5Y avg (0.44%)
Annual Rate
CNY 0.04Paid annual
Payout Ratio
42.9%Sustainable
Last Ex-Dividend
Jun 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.82BCNY420.48M · vs all stocks (USD)
Trailing P/E
74.56xRevenue (TTM)
784.40MCNY117.05M · vs all stocks (USD)
Profit Margin
4.99%Beta
0.2130xvs all stocks
52-Week Change
-23.58%vs all stocks
Market Capitalization
2.82BCNY420.48M · vs all stocks (USD)
Enterprise Value
2.67BCNY398.85M · vs all stocks (USD)
Trailing P/E
74.56xForward P/E
15.25xPrice to Sales (TTM)
3.59xPrice to Book (MRQ)
1.19xEnterprise to Revenue
3.41xEnterprise to EBITDA
17.30xGross Margin
27.73%Profit Margin
4.99%Operating Margin
-0.03%Return on Assets (TTM)
0.40%Return on Equity (TTM)
1.66%Revenue (TTM)
784.40MCNY117.05M · vs all stocks (USD)
Revenue per Share (TTM)
1.87CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-17.40%Gross Profit (TTM)
178.92MCNY26.70M · vs all stocks (USD)
EBITDA (TTM)
118.86MCNY17.74M · vs all stocks (USD)
Net Income (TTM)
39.18MCNY5.85M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-84.60%Operating Cash Flow (TTM)
165.38MCNY24.68M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-28.38MCNY-4.24M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0400CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.60%vs all stocks
5-Year Average Dividend Yield
0.44%vs all stocks
Payout Ratio
42.92%Revenue
828.66MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
577.93MCNYFY2025 · Dec 31, 2025Gross Profit
250.73MCNYFY2025 · Dec 31, 2025Operating Income
126.62MCNY18.89M · vs all stocks (USD)
Pre-tax Income
75.58MCNYFY2025 · Dec 31, 2025Income Tax Expense
2.49MCNYFY2025 · Dec 31, 2025Net Income
73.09MCNYFY2025 · Dec 31, 2025EBIT
88.08MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
283.45MCNYFY2025 · Dec 31, 2025Research & Development
64.99MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
22.93MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.25MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
25.52MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
12.50MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1740CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1740CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
420.07MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
420.07MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
73.09MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
30.95MCNYFY2025 · Dec 31, 2025Free Cash Flow
-259.90MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
252.84MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
73.09MCNYFY2025 · Dec 31, 2025Other Non-cash Items
12.92MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-37.20MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-17.87MCNYFY2025 · Dec 31, 2025Capital Expenditures
-290.85MCNYFY2025 · Dec 31, 2025Purchase of Investments
-325.70MCNYFY2025 · Dec 31, 2025Sale of Investments
599.65MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-16.91MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
459.89MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-525.62MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-28.78MCNYFY2025 · Dec 31, 2025Other Financing Charges
-3.46MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-97.96MCNYFY2025 · Dec 31, 2025Shares Outstanding
419.95MSharesUpdated Sep 21, 2026Float Shares
287.01MSharesUpdated Sep 21, 2026% Held by Insiders
33.98%vs all stocks
% Held by Institutions
4.95%vs all stocks
Total Cash (MRQ)
597.68MCNY89.19M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.42CNYUpdated Sep 21, 2026Total Debt (MRQ)
452.70MCNY67.55M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1908xCurrent Ratio (MRQ)
1.93xBook Value per Share (MRQ)
5.65CNYUpdated Sep 21, 2026Total Assets
3.32BCNY495.56M · vs all stocks (USD)
Total Current Assets
1.46BCNYFY2025 · Dec 31, 2025Total Liabilities
955.80MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.86BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
288.88MCNYFY2025 · Dec 31, 2025Total Current Liabilities
666.92MCNYFY2025 · Dec 31, 2025Cash
252.84MCNYFY2025 · Dec 31, 2025Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
252.84MCNYFY2025 · Dec 31, 2025Other Short-term Investments
40.08MCNYFY2025 · Dec 31, 2025Accounts Receivable
117.83MCNYFY2025 · Dec 31, 2025Inventory
510.45MCNYFY2025 · Dec 31, 2025Accounts Payable
179.12MCNYFY2025 · Dec 31, 2025Short-term Debt
449.29MCNYFY2025 · Dec 31, 2025Long-term Debt
187.22MCNYFY2025 · Dec 31, 2025Common Stock (Book)
419.95MCNYFY2025 · Dec 31, 2025Retained Earnings
624.45MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.37BCNY352.94M · vs all stocks (USD)
52-Week Low
6.11CNYUpdated Sep 21, 202652-Week High
8.95CNYUpdated Sep 21, 202652-Week Change
-23.58%vs all stocks
Beta
0.2130xvs all stocks
50-Day MA
6.85CNYUpdated Sep 21, 2026200-Day MA
7.46CNYUpdated Sep 21, 2026Avg 10-Day Volume
4.31MSharesUpdated Sep 21, 2026Avg 30-Day Volume
5.69MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.0900CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.66: safe zoneNotable
Altman Z-Score: 2.66
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Kyverna Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shaanxi Panlong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Deva Holding A.S.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Canopy Growth Corporation
Tier 1ProductionApproval-Gated PipelineFlowRule
Tuoxin Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Orum Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang East-Asia Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Allgens Medical Technology Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hua Medicine Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Prothena Corporation plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Nazara Technologies Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
NIOX Group plc
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Seobu T&D Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth